FGF21 and Its Role in Lipid Metabolism
Author Information
Author(s): Yusuke Murata, Morichika Konishi, Nobuyuki Itoh
Primary Institution: Kyoto University Graduate School of Pharmaceutical Sciences
Hypothesis
FGF21 acts as an endocrine regulator in lipid metabolism.
Conclusion
FGF21 is a metabolic regulator and a biomarker for metabolic diseases, but it may not be physiologically essential for certain hepatic functions.
Supporting Evidence
- FGF21 levels are increased in patients with metabolic diseases having insulin resistance.
- FGF21 inhibits lipolysis in adipocytes during fasting.
- FGF21 plays a role in glucose metabolism and has potential therapeutic effects on metabolic diseases.
Takeaway
FGF21 is a protein that helps control how our body uses fats and sugars, especially when we don't eat for a while. It can be a sign of health problems when its levels are high.
Methodology
The study involved experiments with Fgf21 transgenic and knockout mice, as well as cultured cells to assess the effects of FGF21 on metabolism.
Limitations
The physiological roles of FGF21 may differ from its pharmacological effects, and knockout mice studies suggest it is not essential for certain metabolic processes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website